UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2012, Volume 119, Issue 8, pp. 1596 - 1603
Ophthalmology | Life Sciences & Biomedicine | Science & Technology | Tumors and pseudotumors of the eye, orbit, eyelid, lacrimal apparatus | Biological and medical sciences | Miscellaneous | Medical sciences | Uveal Neoplasms - genetics | Prognosis | Prospective Studies | Uveal Neoplasms - pathology | Follow-Up Studies | Oligonucleotide Array Sequence Analysis | Humans | Middle Aged | Male | Gene Expression Profiling | Melanoma - pathology | Young Adult | Melanoma - genetics | Adolescent | Aged, 80 and over | Adult | Female | Aged | Biomarkers, Tumor - genetics | Polymorphism, Single Nucleotide | Gene Expression Regulation, Neoplastic - physiology | Real-Time Polymerase Chain Reaction | Chromosomes, Human, Pair 3 - genetics | Universities and colleges | Metastasis | Gene expression | Genes | Melanoma | Index Medicus
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 0027-8424, 4/2010, Volume 107, Issue 16, pp. 7401 - 7406
Macular degeneration | Drusen | Genes | Alleles | Disease risk | Genetic loci | P values | Disease susceptibility | Chromosomes | Genotypes | Genome-wide association study | Single nucleotide polymorphism | Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Genetic Predisposition to Disease | Genome-Wide Association Study | Humans | Lipoproteins, HDL - metabolism | Complement Factor I - genetics | Genotype | Risk | Chromosome Mapping | Tissue Inhibitor of Metalloproteinase-3 - physiology | Case-Control Studies | Genetic Variation | Regression Analysis | Macular Degeneration - genetics | Polymorphism, Single Nucleotide | Tissue Inhibitor of Metalloproteinase-3 - genetics | Genetic susceptibility | High density lipoproteins | Physiological aspects | Genetic aspects | Single nucleotide polymorphisms | Properties | Identification and classification | Risk factors | Studies | Genotype & phenotype | Enzymes | Lipoproteins | Pathogenesis | Genetics | Comparative analysis | Index Medicus | Biological Sciences | single nucleotide polymorphism | genome-wide association study
Journal Article
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2015, Volume 122, Issue 9, pp. 1846 - 1853.e5
Ophthalmology | Life Sciences & Biomedicine | Science & Technology | Antibodies, Monoclonal, Humanized - therapeutic use | Prospective Studies | Intravitreal Injections | Tomography, Optical Coherence | Humans | Middle Aged | Geographic Atrophy - physiopathology | Cicatrix - diagnosis | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Bevacizumab | Retinal Pigment Epithelium | Wet Macular Degeneration - drug therapy | Ranibizumab | Angiogenesis Inhibitors - therapeutic use | Retina - pathology | Visual Acuity - physiology | Fluorescein Angiography | Macular degeneration | Clinical trials | Physiological aspects | Comparative analysis | Drug therapy | Index Medicus
Journal Article
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2015, Volume 122, Issue 2, pp. 391 - 398.e5
Ophthalmology | Life Sciences & Biomedicine | Science & Technology | Choroidal Neovascularization - diagnosis | Prospective Studies | Follow-Up Studies | Intravitreal Injections | Humans | Male | Wet Macular Degeneration - physiopathology | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Bevacizumab | Angiogenesis Inhibitors - administration & dosage | Retinal Hemorrhage - diagnosis | Antibodies, Monoclonal, Humanized - administration & dosage | Choroidal Neovascularization - drug therapy | Ranibizumab | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Female | Visual Acuity - physiology | Fluorescein Angiography | Retinal Hemorrhage - physiopathology | Antibodies, Monoclonal, Humanized - therapeutic use | Tomography, Optical Coherence | Treatment Outcome | Choroidal Neovascularization - physiopathology | Wet Macular Degeneration - diagnosis | Wet Macular Degeneration - drug therapy | Aged | Retinal Hemorrhage - drug therapy | Cohort Studies | Macular degeneration | Clinical trials | Physiological aspects | Comparative analysis | Drug therapy | Index Medicus
Journal Article
Science (American Association for the Advancement of Science), ISSN 0036-8075, 2019, Volume 365, Issue 6456, pp. 897 - 902
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Earth | Archaeology | Transformation | Hunter-gatherers | Human influences | Environmental changes | Trajectories | Earth surface | Holocene | Land use | Anthropogenic factors | Index Medicus | Geography | Humanities and Social Sciences | Architecture, space management | Archaeology and Prehistory
Journal Article
The New England journal of medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 5, pp. 419 - 430
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Vasoconstrictor Agents - therapeutic use | Catecholamines - administration & dosage | Double-Blind Method | Vasoconstrictor Agents - adverse effects | Humans | Middle Aged | Shock - physiopathology | Male | Hypotension - drug therapy | Shock - drug therapy | Female | Organ Dysfunction Scores | Aged | Blood Pressure - drug effects | Angiotensin II - adverse effects | Drug Therapy, Combination | Angiotensin II - therapeutic use | Dilatation | Angiotensin | Blood vessels | Blood pressure | Research | Health aspects | Testing | Shock | Intensive care | Mortality | Critical care | Death | Norepinephrine | Angiotensin II | Drug therapy | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
JAMA ophthalmology, ISSN 2168-6165, 03/2019, Volume 137, Issue 5, pp. 543 - 550
Life Sciences & Biomedicine | Ophthalmology | Science & Technology | United States | Humans | Middle Aged | Calcium - administration & dosage | Proportional Hazards Models | Geographic Atrophy - etiology | Male | Diet | Wet Macular Degeneration - etiology | Aged, 80 and over | Female | Aged | Dietary Supplements | Macular degeneration | Atrophy | Women | Calcium (dietary) | Dietary supplements | Eye diseases | Retina | Dietary intake | Supplementation | Age | Index Medicus | Abridged Index Medicus | Online First | Original Investigation | Research
Journal Article
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2011, Volume 118, Issue 10, pp. 1916 - 1926
Ophthalmology | Life Sciences & Biomedicine | Science & Technology | Biological and medical sciences | Miscellaneous | Medical sciences | Uvea diseases | Visual Fields - physiology | Fluocinolone Acetonide - administration & dosage | Glucocorticoids - administration & dosage | Humans | Middle Aged | Drug Implants | Male | Uveitis, Intermediate - physiopathology | Uveitis, Posterior - physiopathology | Uveitis, Posterior - diagnosis | Uveitis, Intermediate - diagnosis | Panuveitis - diagnosis | Female | Drug Therapy, Combination | Visual Acuity - physiology | Immunosuppressive Agents - administration & dosage | Prednisone - administration & dosage | Sickness Impact Profile | Treatment Outcome | Uveitis, Posterior - drug therapy | Panuveitis - physiopathology | Macular Edema - drug therapy | Quality of Life | Panuveitis - drug therapy | Uveitis, Intermediate - drug therapy | Medical colleges | Corticosteroids | Anti-inflammatory drugs | Immunotherapy | Uveitis | Clinical trials | Comparative analysis | Public health | Index Medicus
Journal Article